Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals Share Price Chart
Pharmaids Pharmaceuticals last traded at ₹30.01 (2026-10-13). Over the past month the stock moved +1.0%, three months the stock moved +5.4%, year the stock moved -50.8%. Its closing range over 52 weeks is ₹28.47 – ₹50.50, with the latest close 40.6% below the high.
Closing prices up to 2026-10-13.
About Pharmaids Pharmaceuticals
Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services. It is undergoing a business transition and aims to build a CRDMO platform.[1]
Business Overview[1] The company is engaged in research, development, and manufacturing services. It is pursuing organic and inorganic growth opportunities and is in the process of a business transition, including strengthening its leadership team. It is working towards establishing a Contract Research, Development, and Manufacturing Organization (CRDMO) to offer integrated services across pharma, biopharma, agrochemicals, medical devices, and specialty chemicals for domestic and international markets.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Pharmaids Pharmaceuticals reported sales of ₹4.12 crore (-38.1%) and net profit of ₹1.88 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 4.12 | -0.75 | -18.20 | 1.88 | 0.63 |
| Mar 2026 | 7.18 | -0.34 | -4.74 | -1.09 | -0.51 |
| Dec 2025 | 5.43 | -2.51 | -46.22 | -2.65 | -0.70 |
| Sep 2025 | 8.61 | -5.32 | -61.79 | -2.57 | -0.71 |
| Jun 2025 | 6.66 | -5.37 | -80.63 | -5.27 | -1.39 |
| Mar 2025 | 4.77 | -3.90 | -81.76 | -4.80 | -1.12 |
| Dec 2024 | 4.71 | -2.89 | -61.36 | -3.01 | -0.55 |
| Sep 2024 | 5.24 | -2.41 | -45.99 | -2.27 | -0.55 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | +23450.0% | -17.9% | +40.8% | +64.3% | +15.3% | +50.5% | -38.1% |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -46.0% | -61.4% | -81.8% | -80.6% | -61.8% | -46.2% | -4.7% | -18.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Pharmaids Pharmaceuticals reported sales of ₹28.00 crore (+47.4%) and net profit of ₹-12.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 28.00 | -14.00 | -49.00 | -12.00 | -3.32 |
| Mar 2025 | 19.00 | -13.00 | -66.00 | -14.00 | -3.06 |
| Mar 2024 | 15.00 | -13.00 | -87.00 | -12.00 | -2.26 |
| Mar 2023 | 0.00 | -10.00 | – | -8.00 | -3.52 |
| Mar 2022 | 4.00 | 0.00 | 3.00 | 0.00 | 0.15 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | -100.0% | – | +26.7% | +47.4% |
| Operating profit growth | – | – | – | – |
| Net profit growth | – | – | – | – |
| EPS growth | -2446.7% | – | – | – |
| OPM % | – | -87.0% | -66.0% | -49.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Pharmaids Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
-
Pharmaids Pharmaceuticals announces divestment of step-down subsidiary - Business Standard
-
Pharmaids Pharmaceuticals announces divestment of step-down subsidiary - Business Standard
-
Pharmaids Pharmaceuticals announces divestment of step-down subsidiary - business-standard.com
-
Pharmaids Pharmaceuticals announces divestment of step-down subsidiary - Business Standard
Frequently Asked Questions
What is Pharmaids Pharmaceuticals's current stock price?
Pharmaids Pharmaceuticals shares were last quoted at ₹30.01 (-2.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Pharmaids Pharmaceuticals?
Pharmaids Pharmaceuticals has a price-to-earnings (P/E) ratio of -26.45 and a price-to-book (P/B) ratio of 2.11. The industry P/E is 52.82.
What is the 52-week high and low of Pharmaids Pharmaceuticals?
The 52-week high of Pharmaids Pharmaceuticals is ₹66.00 and the 52-week low is ₹25.60.
What is the market cap of Pharmaids Pharmaceuticals?
The market capitalisation of Pharmaids Pharmaceuticals is about ₹104.46 crore.
How did Pharmaids Pharmaceuticals perform in its latest quarterly results?
In the latest quarter (Jun 2026), Pharmaids Pharmaceuticals reported sales of ₹4.12 crore (-38.1%) and net profit of ₹1.88 crore, compared with the same quarter last year.
Is Pharmaids Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Pharmaids Pharmaceuticals has a 3-year ROE of -19.00%, 3-year profit growth of -50.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Pharmaids Pharmaceuticals?
Promoters hold about 32.99% of Pharmaids Pharmaceuticals.
Which sector does Pharmaids Pharmaceuticals belong to?
Pharmaids Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.